About Biocard Dengue IgG/IgM Antibody (DipStick)
overview
Biocard Dengue IgG/IgM dipstick Test is a rapid immunochromatographic lateral flow assay for the qualitative differential detection of IgG and IgM antibodies to Dengue infection by Monoclonal Antibody Capture (MAC) method.
- All the accessories needed for the sampling and testing are included.
- Works on Serum/Plasma and Whole Blood.
- Results can be obtained in 20 minutes.
Features
- Sample Type: Serum/Plasma and Whole blood.
- Ability to differentially detect Dengue IgM and IgG antibody.
- Convenient pack sizes.
- Simple to perform.
- Results can be obtained in 20 minutes.
- Needs no equipment.
- Excellent sensitivity and specificity.
- Convenient storage between 4-30C.
- ISO -13485 2012 and GMP compliant manufacturing process.
Technical Specifications
Biocard Dengue IgG/IgM Antibody In Vitro Diagnostic Kit (DipStick)
Advanced Portable DetectionThe Biocard Dengue IgG/IgM Antibody (DipStick) leverages cutting-edge technology to provide rapid and accurate dengue diagnosis. Its portable design allows medical professionals to carry and use it conveniently within hospital and clinic environments, ensuring prompt testing and results directly at the point of care.
Reliable Multicolor IndicatorsDesigned with a clear multicolor format, the DipStick test delivers easy-to-interpret results. The distinct colors aid healthcare workers in quickly identifying the presence of IgG and IgM antibodies, which facilitates appropriate and timely clinical decisions during dengue fever outbreaks.
FAQs of Biocard Dengue IgG/IgM Antibody (DipStick):
Q: How is the Biocard Dengue IgG/IgM Antibody (DipStick) used in medical settings?
A: This DipStick is used by healthcare professionals to detect the presence of IgG and IgM antibodies to the dengue virus in patients blood samples, providing rapid results that aid in diagnosis.
Q: What benefits does the multicolor feature offer in the Biocard DipStick?
A: The multicolor result indicators make it straightforward to differentiate between IgG and IgM antibodies, enhancing result accuracy and minimizing interpretation errors for clinicians.
Q: When should the Biocard Dengue IgG/IgM Antibody test be administered?
A: This test is typically administered to patients presenting with symptoms of dengue fever or where dengue infection is suspected, enabling prompt identification and treatment.
Q: Where can the Biocard Dengue IgG/IgM Antibody (DipStick) be utilized?
A: The DipStick is designed for hospital and clinic use but its portable nature also allows utilization in field or emergency scenarios where laboratory access is limited.
Q: What is the process for using the Biocard Dengue DipStick in clinical practice?
A: A blood sample is collected and applied to the test dipstick. After waiting for the reaction to occur, clinicians interpret the multicolor results to determine dengue antibody presence.
Q: What advantages do hospitals and clinics in India gain from this product?
A: Hospitals and clinics benefit from the DipSticks rapid results, portability, and reliability, enabling faster diagnosis and better patient management, especially in high-dengue-incidence areas.